🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/01/1980 | 1,93 | 1,99 | 1,93 | 1,99 | +2,91% | 3,60% | 3.263.472 |
| 07/01/1980 | 1,92 | 1,96 | 1,92 | 1,93 | +0,87% | 2,25% | 1.905.264 |
| 04/01/1980 | 1,91 | 1,94 | 1,91 | 1,92 | +0,69% | 1,73% | 2.018.448 |
| 03/01/1980 | 1,88 | 1,90 | 1,84 | 1,90 | +1,41% | 3,18% | 2.176.906 |
| 02/01/1980 | 1,92 | 1,93 | 1,87 | 1,88 | -2,07% | 2,77% | 4.206.672 |
| 31/12/1979 | 1,94 | 1,94 | 1,92 | 1,92 | -1,20% | 1,54% | 758.333 |
| 28/12/1979 | 1,94 | 1,94 | 1,93 | 1,94 | -0,34% | 0,68% | 837.562 |
| 27/12/1979 | 1,92 | 1,94 | 1,92 | 1,94 | +1,20% | 1,20% | 830.016 |
| 26/12/1979 | 1,93 | 1,93 | 1,92 | 1,92 | -0,51% | 0,68% | 762.106 |
| 24/12/1979 | 1,94 | 1,94 | 1,93 | 1,93 | -0,85% | 0,85% | 596.102 |
| 21/12/1979 | 1,94 | 1,95 | 1,94 | 1,95 | +0,86% | 0,35% | 1.222.387 |
| 20/12/1979 | 1,91 | 1,93 | 1,91 | 1,93 | +1,22% | 1,21% | 2.139.178 |
| 19/12/1979 | 1,92 | 1,92 | 1,90 | 1,91 | -0,34% | 1,04% | 3.116.333 |
| 18/12/1979 | 1,94 | 1,95 | 1,92 | 1,92 | -1,36% | 1,71% | 3.022.013 |
| 17/12/1979 | 1,95 | 1,96 | 1,93 | 1,94 | -0,34% | 1,70% | 2.920.147 |
| 14/12/1979 | 1,91 | 1,95 | 1,91 | 1,95 | +2,44% | 2,09% | 3.655.843 |
| 13/12/1979 | 1,91 | 1,92 | 1,90 | 1,90 | -0,17% | 1,04% | 1.478.938 |
| 12/12/1979 | 1,92 | 1,92 | 1,90 | 1,91 | -0,86% | 0,69% | 2.222.179 |
| 11/12/1979 | 1,94 | 1,94 | 1,92 | 1,92 | -1,02% | 1,36% | 2.448.547 |
| 10/12/1979 | 1,95 | 1,95 | 1,91 | 1,94 | -0,51% | 2,04% | 2.154.269 |
| 07/12/1979 | 1,95 | 1,97 | 1,95 | 1,95 | +0,17% | 1,02% | 3.293.654 |
| 06/12/1979 | 1,92 | 1,95 | 1,92 | 1,95 | +1,91% | 1,73% | 2.252.362 |
| 05/12/1979 | 1,92 | 1,93 | 1,91 | 1,91 | -0,34% | 1,38% | 1.622.304 |
| 04/12/1979 | 1,90 | 1,93 | 1,89 | 1,92 | +1,22% | 1,75% | 2.041.085 |
| 03/12/1979 | 1,91 | 1,91 | 1,89 | 1,90 | -1,21% | 0,87% | 1.524.211 |
| 30/11/1979 | 1,94 | 1,94 | 1,92 | 1,92 | -1,36% | 1,03% | 1.901.491 |
| 29/11/1979 | 1,96 | 1,96 | 1,93 | 1,94 | -0,68% | 1,35% | 1.063.930 |
| 28/11/1979 | 1,93 | 1,96 | 1,91 | 1,96 | +1,20% | 2,40% | 1.516.666 |
| 27/11/1979 | 1,94 | 1,96 | 1,93 | 1,93 | -0,17% | 1,54% | 2.033.539 |
| 26/11/1979 | 1,89 | 1,95 | 1,89 | 1,94 | +3,35% | 3,51% | 3.927.485 |